Apimeds Pharmaceuticals US (APUS) Interest Expenses (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Interest Expenses came in at $278415.0 in Q4 2025, up 157.12% YoY from $108281.0 in Q4 2024, and up 4318.58% on a QoQ basis from $6301.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Interest Expenses (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Interest Expenses data on file, last reported at $278415.0 in Q4 2025.
- Quarterly Interest Expenses rose 157.12% year-over-year to $278415.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $345802.0 (up 82.05% YoY) and the FY2025 annual result came in at $2.6 million, up 131.86% from the prior year.
- Interest Expenses climbed to $278415.0 in Q4 2025, from $6301.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $800177.0 in Q4 2023 to a low of $6301.0 in Q3 2025.
- A 3-year average of $148436.6 and a median of $32638.0 in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses tumbled 86.47% — and 2025, when it jumped 157.12%.
- Tracing APUS's Interest Expenses over 3 years: stood at $800177.0 in 2023, then plunged by 86.47% to $108281.0 in 2024, then jumped by 157.12% to $278415.0 in 2025.
- The last three Interest Expenses figures came in at $278415.0 (Q4 2025), $6301.0 (Q3 2025), and $23054.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.12 Mn | 7.12 Mn | - | 3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 278,415.00 |
| Dec 31, 2025 | 278,415.00 |
| Sep 30, 2025 | 6,301.00 |
| Sep 30, 2025 | 6,301.00 |
| Jun 30, 2025 | 23,054.00 |
| Jun 30, 2025 | 23,054.00 |
| Mar 31, 2025 | 38,032.00 |
| Mar 31, 2025 | 38,032.00 |
| Dec 31, 2024 | 108,281.00 |
| Dec 31, 2024 | 108,281.00 |
| Sep 30, 2024 | 32,638.00 |
| Sep 30, 2024 | 32,638.00 |
| Jun 30, 2024 | 22,123.00 |
| Jun 30, 2024 | 22,123.00 |
| Mar 31, 2024 | 26,908.00 |
| Mar 31, 2024 | 26,908.00 |
| Dec 31, 2023 | 800,177.00 |
| Dec 31, 2023 | 800,177.00 |